2024 HCPCS Code C9024
Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine
TAGS: cytarabine daunorubicin
Notice | HCPCS C9024 terminated on December 31, 2018. |
Short Description | Inj, daunorubicin-cytarabine |
HCPCS Coverage Code | D - Special coverage instructions apply |
HCPCS Action Code | N - No maintenance for this code |
HCPCS Action Effective Date | January 01, 2019 |
HCPCS Code Added Date | January 01, 2018 |
HCPCS Pricing Indicator Code | 53 - Statute |
HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
HCPCS Coverage Issues Manual Reference Section Number | |
HCPCS Type Of Service Code | 9 - Other medical items or services |
HCPCS Anesthesia Base Unit Quantity | 0 |
Check Similar HCPCS Codes
- C9483 - Injection, atezolizumab
- C9484 - Injection, eteplirsen
- C9485 - Injection, olaratumab
- C9486 - Inj, granisetron ext
- C9487 - Ustekinumab iv inj, 1 mg
- C9488 - Conivaptan hcl
- C9489 - Injection, nusinersen
- C9490 - Injection, bezlotoxumab
- C9491 - Injection, avelumab
- C9492 - Injection, durvalumab
- C9493 - Injection, edaravone
- C9494 - Injection, ocrelizumab
- C9497 - Loxapine, inhalation powder
- C9507 - Covid-19 convalescent plasma
- C9600 - Perc drug-el cor stent sing
- C9601 - Perc drug-el cor stent bran
- C9602 - Perc d-e cor stent ather s
- C9603 - Perc d-e cor stent ather br
- C9604 - Perc d-e cor revasc t cabg s
- C9605 - Perc d-e cor revasc t cabg b